The best pharmaceutical executive recruiters understand the science well enough to judge a chief scientific officer, and the business well enough to judge whether a chief commercial officer can launch a first product. Good life science executive search firms know which leaders have taken an asset from preclinical work into the clinic, who has handled an FDA advisory committee, and which board candidates bring public company or financing experience a venture-backed biotech needs. The firms below include global practices that cover biopharma, medtech and life science tools, plus specialists that recruit only in life sciences.
Every firm was checked against its own website for its life sciences focus, the sectors and roles it covers, its services and its location, and facts we could not confirm were left out. The ranking is editorial. For more on how searches work and how much they cost, see our executive search hub, and if you are building a biotech board, our guide to board director search.
| Firm | Headquarters | Best For | Core Services |
| Heidrick & Struggles | Chicago, Illinois | Global biopharma and medtech C-suite and board roles | Executive search, board advisory, assessment, on-demand talent |
| Spencer Stuart | Chicago, Illinois | Biopharma CEO, R&D and board searches | Executive search, board services, leadership advisory |
| Egon Zehnder | Zurich, Switzerland | Pharma CEO succession and board composition | Executive search, CEO succession, board consulting, leadership assessment |
| Coulter Partners | London, UK (US base in Cambridge, Massachusetts) | Cross-border biotech and life science searches | Executive search, board advisory, leadership consulting |
| Klein Hersh | Horsham, Pennsylvania | Clinical development, regulatory and drug safety leaders | Executive search, interim staffing, corporate expansion and relocation |
| DSG (BioQuest) | Philadelphia, Pennsylvania | Emerging growth biotech, medtech and diagnostics | Retained executive search, board recruitment |
| Slone Partners | Fort Lauderdale, Florida | Venture and PE-backed life sciences companies | Executive search, fractional talent |
| The Bowdoin Group | Boston, Massachusetts | Investor-backed healthcare and life sciences teams | Executive search, strategic search, team builds |
| Ashton Tweed | King of Prussia, Pennsylvania | Interim and interim-to-hire life sciences executives | Retained search, interim executives |
| Christian & Timbers | San Francisco Bay Area | Biotech and biopharma leaders at the intersection of science and technology | Executive search, board search |
Heidrick & Struggles runs a combined Healthcare & Life Sciences practice with six stated focus areas: biopharmaceuticals, disruptive healthcare, health tech, healthcare services, life sciences tools and services, and medical technology. It works with established pharmaceutical and medical technology companies as well as early-stage therapy and platform companies, and advises boards and leadership teams using assessment tools alongside search.
Regional managing partners for the practice sit in Boston, Singapore, Milan and Rome, which gives the firm reach into the main biotech clusters in the US, Europe and Asia. Its recent life sciences insights cover European pharma execution and blended talent models that combine permanent and on-demand leaders. It is a strong choice for a global pharma company replacing a division head or a public biotech rebuilding its board.
Spencer Stuart’s biopharma practice states that it has conducted more than 700 executive and board assignments for biotechnology and pharmaceutical companies over the past three years, ranging from startups to the large companies that account for half of sector revenue. It also works in adjacent segments: animal health, consumer healthcare, contract research and manufacturing, contract sales organizations, pharmaceutical services and generics.
Functional depth covers research and development, manufacturing and quality, managed markets and reimbursement, and human resources. Many of its consultants are former CEOs and senior managers, often with scientific or medical credentials. The firm also runs separate medical technology and healthcare services practices, so a medtech company can draw on the same firm for board and executive work. It suits companies that want a single firm across several senior hires.
Egon Zehnder’s biopharmaceuticals practice reports more than 35 dedicated consultants worldwide, more than 300 assignments closed each year, more than 30 board consulting engagements a year and more than 20 CEO searches and succession plans delivered annually. It works with established pharmaceutical companies and emerging biotech innovators across the value chain.
The firm’s health group also has separate practices for medical devices, diagnostics and technology, life sciences tools and pharmaceutical services, and healthcare delivery. Its work centers on boards and CEOs: CEO and C-suite succession, board composition and effectiveness, and leadership assessment and development. Companies planning a CEO transition two or three years out, rather than filling an urgent vacancy, will get the most from its approach, since the work starts well before a vacancy opens.
Coulter Partners specializes in executive search and leadership development for life sciences, health and technology. It reports about 400 assignments a year in more than 40 countries and 85 search professionals across its offices. Its European headquarters is in London and its US headquarters in Cambridge, Massachusetts, with further offices in Los Angeles, Short Hills (New Jersey), Brussels, Lyngby, Paris, Frankfurt, Milan, Zug and Melbourne.
Services cover executive search, board advisory and leadership consulting. Recent placements announced on its site include a CEO for Valo Therapeutics and a chief medical officer for NRG Therapeutics. The office map tracks the main biotech hubs closely, which makes Coulter a natural fit for a US biotech hiring a European head of operations or a European company building a US commercial team.
Klein Hersh has recruited for life sciences and healthcare since 1998 and is based in Horsham, Pennsylvania. It calls itself a precision executive search firm, and its expertise list is unusually granular: CEO, CBO, CCO, CSO, CFO and COO roles; oncology, CNS and rare disease; board of directors; clinical development and clinical operations; data science; pharma services, CROs, CDMOs and generics; regulatory, quality and manufacturing; drug safety; and commercialization.
Beyond executive search, it supports interim staffing and corporate expansion and relocation, and it shares market insight to help clients plan leadership roles and compensation and equity programs. That function-by-function depth helps companies hiring a head of pharmacovigilance or a vice president of regulatory affairs, roles where a generalist firm may struggle to build a full slate.
DSG Global built its life sciences practice on the acquisition of BioQuest and says the practice has more than 30 years of experience recruiting in the field. It covers pharmaceutical, medical device, biotechnology, diagnostics, precision medicine, digital health, research institutions and private equity and venture capital clients.
The practice recruits director, vice president and C-level talent across R&D, clinical and commercial functions, as well as independent board members for public and private emerging growth companies and venture-backed portfolio companies. Managing directors stay strategic and hands-on with every element of each retained search engagement. DSG fits investors and boards building out leadership teams at several portfolio companies at once, since the firm also has dedicated private capital work and a board and governance advisory team.
Slone Partners has placed leaders in life sciences and healthcare organizations for more than 25 years, and its site lists offices nationwide with a contact address in Fort Lauderdale, Florida. Its sector coverage includes life sciences, healthcare, health tech and AI, hospitals and healthcare delivery, private equity, venture capital and nonprofits.
Alongside executive search, Slone offers fractional talent for companies that need senior expertise without a full-time hire. Recent placements it has announced include a CEO for Perspectum, a CEO for SeqCenter and a chief scientific officer for Prolynx. The fractional option is helpful for early-stage companies that need a chief medical officer or head of regulatory for a defined phase, such as an IND filing, before committing to a permanent hire.
The Bowdoin Group is an executive search and talent advisory firm for healthcare and life sciences companies, based in Boston. It cites more than 30 years of experience and more than 12,500 placements, and reports an average Net Promoter Score of 90 across candidates and clients.
Its services go beyond the C-suite. Executive search covers senior leaders, strategic search applies executive search methods to high-impact roles below the executive level, and team builds cover functional hiring up to full team buildouts tied to a launch or scale-up. The firm works closely with investors and operators, which suits a Cambridge or Boston biotech that has just closed a financing round and needs a leadership team plus the layer beneath it, hired on one coordinated plan.
Ashton Tweed serves pharmaceutical, biotechnology, diagnostic and medical device companies with retained executive search and interim executives. Its model centers on an executive talent bank of experienced life sciences executives and industry experts who are ready for interim, permanent or interim-to-hire roles. The firm lists offices in King of Prussia, Pennsylvania, and works with clients across North America, Europe and Asia.
The firm says its life sciences talent bank holds more than 70,000 people and that its partners bring more than 75 years of combined life sciences and human capital experience. Roles cover the C-suite as well as research, HR and regulatory affairs. Interim placements let a company bring in a seasoned head of quality or regulatory quickly and convert a fixed hiring cost into a variable one while it decides on the permanent structure.
Christian & Timbers is best known for technology and AI executive search, and it runs dedicated biotech and biopharma practices that draw on that background. The firm states that it has placed more than 100 leaders across biopharma and life sciences, from clinical development through commercialization, with typical placements including CEOs, chief scientific officers, chief medical officers, chief commercial officers and board directors.
Its biotech searches also cover chief technology officers, chief operating officers and vice presidents of clinical development and regulatory affairs. That mix is useful for companies whose science depends on data platforms, computational biology or AI, where the right leader needs to work across lab science and software. Published case studies include a first-ever CTO hire at Atropos Health and a chief commercial officer for Dab Bio, and candidate testimonials on its site describe board roles at Telix Pharmaceuticals and a global radiopharmaceutical company.
For scientific and clinical roles, yes in most cases. A specialist can judge whether a chief medical officer’s trial experience matches your modality and phase. For CEO and board roles at larger companies, global firms add board advisory and assessment depth. Many companies shortlist one of each and compare their proposed candidate approach in the pitch.
Most retained searches take about three to five months from kickoff to signed offer, and longer when candidates face notice periods or equity vesting. Interim placements move faster. Our guide to the executive search process walks through each stage and where searches usually stall.
Interim and fractional leaders suit defined phases: an IND or NDA submission, a manufacturing transfer, or the gap after an unexpected departure. Firms such as Ashton Tweed and Slone Partners offer these models alongside permanent search. Compare the options in our guide to interim vs fractional executives.
Retained search typically costs about one-third of the executive’s first-year total cash compensation. In biotech, ask how the firm treats sign-on equity and bonuses in that calculation, since the answer can move the fee a lot. Our guide to executive search fees explains common structures.
Ask for comparable searches completed in the last two years at the same stage and modality, the names of the people who will run your search, and the companies the firm cannot approach because of client restrictions. Large pharma off-limits lists can shrink the candidate pool sharply. To compare these firms with generalist options, see our list of the best executive search firms.
The best pharmaceutical executive recruiter for you depends on stage, modality and role. Global practices at Heidrick & Struggles, Spencer Stuart and Egon Zehnder suit CEO succession and board work at established companies. Christian & Timbers fits biotechs where science meets data and AI. Specialists such as Coulter Partners, Klein Hersh, Slone Partners, Bowdoin and Ashton Tweed go deep on clinical, regulatory and commercial roles and on flexible interim models.
For guides on fees, assessment, onboarding and board recruiting, visit the executive search hub.